Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
EBITDAEPS (Basic)EPS (Weighted Average and Diluted)Non Operating IncomeOperating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Summit Therapeutics (SMMT) Interest Expenses (2016 - 2024)

Historic Interest Expenses for Summit Therapeutics (SMMT) over the last 6 years, with Q4 2024 value amounting to $9000.0.

  • Summit Therapeutics' Interest Expenses changed N/A to $9000.0 in Q4 2024 from the same period last year, while for Sep 2025 it was $9000.0, marking a year-over-year decrease of 9989.63%. This contributed to the annual value of $8.7 million for FY2024, which is 4723.29% down from last year.
  • Summit Therapeutics' Interest Expenses amounted to $9000.0 in Q4 2024.
  • Summit Therapeutics' Interest Expenses' 5-year high stood at $3.1 million during Q1 2024, with a 5-year trough of $9000.0 in Q4 2024.